New treatments and advances in research are giving renewed hope to people affected by osteoarthritis pain and symptoms. StemGenn Regenerative Wellness provides cell therapy for osteoarthritis to help those with unmet clinical needs achieve better health and quality of life.
The majority of complications in osteoarthritis patients are linked to the deterioration of cartilage — the firm, slippery tissue that cushions the ends of bones and permits nearly frictionless joint motion. In osteoarthritis, this surface becomes rough, and as cartilage wears down completely, the patient is left with bone rubbing on bone.
PRP, BMAC and SVF therapy with rehabilitation — provided by StemGenn — is designed to target affected areas within the joints to support the creation or healing of new cartilage cells.
Mesenchymal stem cells (MSCs) are multipotent: they have the ability to differentiate into cartilage cells (chondrocytes). The goal of each stem cell treatment is to inject these cells into the joint to support the formation of new chondrocyte cells.
Stem cells also act as natural anti-inflammatories, helping reduce osteoarthritis pain and swelling within the joint area.
An exclusive regenerative rehabilitation procedure developed by StemGenn for osteoarthritis and cartilage repair.
Existing cell therapies such as PRP, BMAC and SVF generally involve minimal manipulation and same-sitting injections. Other procedures — for example, autologous chondrocyte implantation — require surgically debriding the cartilage defect, taking a biopsy of healthy cartilage, culturing the cells in an external laboratory, and re-implanting them two weeks later.
RECLIMB starts with harvesting the patient's own adipose tissue. Adipose-derived cells have a high regeneration capacity and excellent viability. The harvested fat tissue is processed to separate the Stromal Vascular Fraction (SVF) and microfragmented adipose tissue, which is then combined with Platelet-Rich Fibrin.
Using a rapid isolation protocol, the adipose tissue is processed and homogenised into micro and nanofat. Mixing this Microfragmented Adipose Tissue (MAT) with Leukocyte-rich Platelet-Rich Plasma (LPRP) from the patient's own blood provides sufficient cells to be immediately re-injected into the patient — in a single sitting.
This is a highly innovative procedure that requires an intricate balance: loading enough cells to grow into healthy tissue, but not overloading the space so that cells are not compressed when the patient begins rehabilitation.
Recovery is a guided, structured process. The timeline below reflects typical milestones for cell-based cartilage repair patients.
Most patients return home on the day of the procedure.
Patients can typically resume normal daily activities within a few days of surgery.
Most patients can return to physical activities within three to four months of the procedure.
A full return to sports generally requires nine to twelve months. This interval allows time for the cartilage to mature and for the patient to regain full muscle control.
StemGenn's regenerative protocols also support patients recovering from post-COVID musculoskeletal complications — including joint pain, muscle weakness, and reduced mobility — using a tailored combination of cell therapy and rehabilitation.
StemGenn's multidisciplinary approach provides the full range of care needed by patients at every stage of knee cartilage repair.
Advanced imaging pinpoints the precise location of the cartilage defect before any intervention — ensuring every surgical decision is guided by an accurate, detailed map of the joint.
Our physiotherapists and rehabilitation trainers assess how to optimise the patient's musculoskeletal control and function before surgery — setting the foundation for a stronger recovery.
Structured rehabilitation programmes guide the patient through recovery, restoring strength and range of motion at a pace matched to the body's natural healing timeline.
Our team manages co-existing conditions that often accompany cartilage damage: joint deformity, ACL and meniscus lesions, avascular necrosis (AVN), and sports injuries.
When a cartilage repair procedure fails, it is most often because contributing factors — the meniscus, knee alignment, or joint stability — were not adequately addressed. StemGenn's multidisciplinary team examines every aspect of a patient's care, which is why our success rate for these complex biological reconstructions remains high.
Book a consultation with our orthopaedic and regenerative medicine team to find out whether cell-based therapy is right for you.
